Park Avenue Securities’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$519K Sell
8,624
-215
-2% -$10K ﹤0.01% 1269
2026
Q1
$319K Buy
8,839
+169
+2% +$7.07K ﹤0.01% 1289
2025
Q4
$408K Buy
8,670
+1,339
+18% +$56.6K ﹤0.01% 1188
2025
Q3
$238K Buy
+7,331
New +$261K ﹤0.01% 1502
2025
Q2
Sell
-9,469
Closed -$395K 1476
2025
Q1
$395K Buy
9,469
+2,074
+28% +$108K ﹤0.01% 924
2024
Q4
$433K Sell
7,395
-181
-2% -$10.7K ﹤0.01% 1132
2024
Q3
$523K Sell
7,576
-693
-8% -$44.8K 0.01% 953
2024
Q2
$528K Buy
8,269
+3,483
+73% +$262K 0.01% 947
2024
Q1
$450K Buy
4,786
+362
+8% +$29.1K 0.01% 1008
2023
Q4
$325K Buy
4,424
+156
+4% +$10K ﹤0.01% 1091
2023
Q3
$266K Buy
+4,268
New +$287K ﹤0.01% 1109

Other funds holding BRKR

Park Avenue Securities's BRKR Position: Q2 2026 in Review

Park Avenue Securities reduced its Bruker (BRKR) stake by 2.4% in Q2 2026, selling an estimated $10K and leaving 8,624 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #1269.

Park Avenue Securities first reported a position in BRKR in Q3 2023 and has held it in 11 quarters since. The position peaked at $528K in Q2 2024. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Park Avenue Securities held 8,624 shares of Bruker worth $519K as of Q2 2026.
  • Park Avenue Securities sold 215 Bruker shares in Q2 2026, an estimated $10K.
  • Bruker made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1269 holding.
  • Park Avenue Securities first reported a position in Bruker in Q3 2023 and has held it in 11 quarters since.
  • Park Avenue Securities's Bruker position peaked at $528K in Q2 2024.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.